
Bladder cancer outcomes differ by sex, with worse results for women despite the higher prevalence in men. Factors include delays in diagnosis due to haematuria perception, health-care access, and inconsistent sex-specific treatment responses. Complex interactions involving microbiome, hormones, gene expression, immunology, and tumour environment contribute to these differences.
Like
Save
Share